Genetic basis of tetracycline resistance in Moraxella (Branhamella) catarrhalis.

Antimicrob Agents Chemother

Department of Pathobiology, University of Washington, Seattle 98195.

Published: September 1990

AI Article Synopsis

Article Abstract

Two-high-level-tetracycline-resistance Moraxella (Branhamella) catarrhalis strains were shown to carry DNA sequences which hybridized with the Tet B probe. The determinant appeared to be located in the chromosome and was nontransferable.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC171936PMC
http://dx.doi.org/10.1128/AAC.34.9.1816DOI Listing

Publication Analysis

Top Keywords

moraxella branhamella
8
branhamella catarrhalis
8
genetic basis
4
basis tetracycline
4
tetracycline resistance
4
resistance moraxella
4
catarrhalis two-high-level-tetracycline-resistance
4
two-high-level-tetracycline-resistance moraxella
4
catarrhalis strains
4
strains carry
4

Similar Publications

Article Synopsis
  • - The text discusses a rare case of phlegmonous gastritis found during an autopsy of a patient who had cirrhosis related to nonalcoholic steatohepatitis.
  • - The patient experienced severe health decline, including anorexia and liver dysfunction, ultimately leading to death due to hepatic failure within two weeks.
  • - The report emphasizes the need for awareness that phlegmonous gastritis can occur as a complication in patients with advanced liver cirrhosis, despite its rare occurrence.
View Article and Find Full Text PDF

Background: Otitis media (OM) is one of the most common infections in young children, arising from bacterial and/or viral infection of the middle ear. Globally, and non-typeable (NTHi) are the predominant bacterial otopathogens. Importantly, common upper respiratory viruses are increasingly recognized contributors to the polymicrobial pathogenesis of OM.

View Article and Find Full Text PDF

Respiratory infections (RI) significantly burden patients, their families, and society. Respiratory infection recurrence (RRI) usually depends on a defect of the immune response, which can be more or less transient and/or selective. In particular, children, older people, heavy smokers, and patients with chronic diseases, characterized by an inadequate immune response, may be at risk of developing RRI.

View Article and Find Full Text PDF

Lascufloxacin hydrochloride to treat bacterial infection.

Drugs Today (Barc)

June 2020

Division of Microbiology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India.

Lascufloxacin hydrochloride (AM-1977) is a novel 8-methoxy fluoroquinolone antibacterial agent with a unique pharmacophore at the 1st and 7th positions of the quinoline nucleus developed by Kyorin Pharmaceutical Co., Ltd. (Tokyo, Japan).

View Article and Find Full Text PDF

Many patients with idiopathic pulmonary fibrosis (IPF) undergo hospitalizations due to pulmonary infections. We retrospectively investigated the characteristics of hospitalizations due to pulmonary infection in patients with IPF to elucidate causative pathogens and mortality. We reviewed patients with IPF who were admitted between January 2008 and December 2014 for pulmonary infections including pneumonia and bronchitis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!